Health Care

Filter By:



Research Team

Use comma-separated ID numbers for each author

Support the Hoover Institution

Join the Hoover Institution's community of supporters in advancing ideas defining a free society.

Support Hoover

Analysis and Commentary

Making Health Insurance Enrollment As Automatic As Possible (Part 2)

by Stan Dorn, James C. Capretta, Lanhee J. Chenvia Health Affairs
Thursday, May 3, 2018

In December 2017, the Republican Congress, working with the Trump administration, repealed the tax penalties enforcing the Affordable Care Act’s (ACA) individual mandate, effective in 2019. Although the degree of the mandate’s efficacy is uncertain, its repeal is sure to lead to additional Americans going without coverage, exacerbating the instability that now affects the individual insurance markets of many states.

In the News

Where Is The Outrage Over Alfie Evans’ Mistreatment?

quoting Thomas Sowellvia 71Republic
Saturday, April 28, 2018

One story getting little attention from the mainstream media is the story of Alfie Evans, a terminally ill toddler prevented from leaving Britain for medical treatment. Alfie has spent more than a year in a semi-vegetative state, suffering from a neurodegenerative disease. Over this span, he was kept alive in the critical care unit of Alder Hey Hospital by artificial ventilation.


Keeping Health Insurance Affordable

by John F. Coganvia PolicyEd
Thursday, April 26, 2018

Preventing insurers from pricing premiums based on risk unintentionally increases costs for everyone else in the marketplace. When healthy people refuse to purchase health insurance due to higher costs, it causes insurers to raise prices even further, further disrupting those who are left in the market.

In the News

Health Policy Consensus Group Calls For Short-Term Health Plan Reform

mentioning Lanhee J. Chenvia Mackinac Center for Public Policy (MI)
Wednesday, April 25, 2018

Organizations across the country urge Centers for Medicare and Medicaid Services to make short-term plans renewable

Analysis and Commentary

Viewpoint: Examining The Science Denial Behind IFOAM—Organics International

by Henry I. Miller, Drew L. Kershenvia Genetic Literacy Project
Wednesday, April 25, 2018

The true-believers in organic agriculture, such as the International Federation of Organic Agriculture Movements (IFOAM—Organics International), are as deluded as those who deny the value of vaccines and, like them, have the potential to inflict tremendous harm.

In the News

Fox, Reason, Capitol Hill, And More Outreach Last Week

quoting Henry I. Millervia American Council on Science and Health
Tuesday, April 24, 2018

Henry Miller, MD, and Alex Berezow, PhD, note the uncomfortable truth a whole lot of people attending science march did not want to admit before the second science march - it was first about being against Trump, second about being against Pruitt, third about being against Republicans, and finally about being for the science issues Democrats accept more readily than Republicans. So a whole lot of signs, a whole lot of anti-science environmental groups sponsoring stuff, and hardly a mention of agriculture (except organic food), medicine (except the alternatives to medicine) and no mention at all of energy.


Scott Atlas On The Lars Larson National Podcast (1:29:50)

interview with Scott W. Atlasvia Lars Larson National Podcast
Friday, April 20, 2018

Hoover Institution fellow Scott Atlas discusses how to fix the high cost of medications by exposing the cost of medications to competition and value seeking purchasers.


Lanhee Chen On The Lars Larson National Podcast (50:45)

interview with Lanhee J. Chenvia Lars Larson National Podcast
Tuesday, April 17, 2018

Hoover Institution fellow Lanhee Chen discusses health care and how to give states the authority to craft solutions that meet the needs of their residents.


Scott Atlas: Moderating Big Pharma Prices While Maintaining The Genius

interview with Scott W. Atlasvia The John Batchelor Show
Wednesday, April 11, 2018

Hoover Institution fellow Scott Atlas discusses his Defining Ideas column "An Overlooked Key To Lower Drug Prices."

Analysis and Commentary

Vincent Rajkumar On The High Price Of Cancer Drugs

by Russell Robertsvia EconTalk
Monday, April 9, 2018

Can a life-saving drug be too expensive? What explains the high price of cancer drugs? Dr. Vincent Rajkumar of the Mayo Clinic talks with EconTalk host Russ Roberts about the high price of cancer drugs--drugs that can cost an American with cancer $300,000 per year and require multiple years of treatment.


Health Care Policy Working Group

The Working Group on Health Care Policy devises public policies that enable more Americans to get better value for their health care dollar and foster appropriate innovations that will extend and improve life.